2Li T,Shotton K. Conventional occlusion versus pharmacolog- ic penalization for amblyopia [J]. Cochrane Database Syst Rev,2009,10(4) : 1910-1911.
3Shotton K,Powell C,Voros G, et al. Interventions for unilat eral refractive amblyopia[J]. Cochrane Database Syst Rev, 2008,8(4) :513-517.
4Sturm V. The lazy eye-contemporary strategies of amblyopia treatment[J].Praxis, 2011,16 (4) :229-235.
5Agervi P,Kugelberg U,Kugelberg M,et al. Randomized eval- uation of spectacles plus alternate-day occlusion to treat am- blyopia[J]. Ophthalmology, 2010,117 (2), 381-387.
6Hwang DJ,Kim YJ, Lee JY. Effect and sustainability of part time occlusion therapy for patients with anisometropic ambly opia aged > or =8 years[J]. Br J Ophthalmol,2010,94(9) 1160-1164.
7Tejedor J, Ogallar C. Comparative efficacy of penalization methods in moderate to mild amblyopia[J]. Am J Ophthal mol,2008,145(3) :562 -569.
9Dadeya S, Vats P, Malik KP. Levodopa/carbidopa in the treatment of amblyopia[J]. J Pediatr Ophthalmol Strabis mus,2009,46(2) :87-90.
10Repka MX,Kraker RT,Beck RW,Atkinson CS,et aI. Pediat- ric Eye Disease Investigator Group. Pilot study of levodopa dose as treatment for residual amblyopia in children aged 8 years to younger than 18 years[J]. Arch Ophthalmol, 2010, 128(9) : 1215-1217.
